CORRESP Filing
Curanex Pharmaceuticals Inc
Date: Aug. 8, 2025 · CIK: 0002025942 · Accession: 0001493152-25-011767
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-282686
Letter
Dominari Securities LLC
Fifth Avenue
New York NY 10022
VIA EDGAR
August 8, 2025
United States Securities and Exchange Commission
Division of Corporation Finance
F Street, N.E.
Washington, D.C. 20549
Re: Curanex Pharmaceuticals Inc. ("Company")
Registration Statement on Form S-1, as amended
File No. 333-282686
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), we, as the representative of the several underwriters of the Company's public offering, hereby join the Company's request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 5:00 p.m., Eastern Time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.
Pursuant to Rule 460 under the Securities Act, we, as the representative of the several underwriters, wish to advise you that there will be distributed to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We, the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very
truly yours,
DOMINARI
SECURITIES LLC
Show Raw Text
CORRESP
1
filename1.htm
Dominari
Securities LLC
725
Fifth Avenue
New
York NY 10022
VIA
EDGAR
August
8, 2025
United
States Securities and Exchange Commission
Division
of Corporation Finance
100
F Street, N.E.
Washington,
D.C. 20549
Re:
Curanex
Pharmaceuticals Inc. ("Company")
Registration
Statement on Form S-1, as amended
File
No. 333-282686
Ladies
and Gentlemen:
Pursuant
to Rule 461 under the Securities Act of 1933, as amended (the "Securities Act"), we, as
the representative of the several underwriters of the Company's public offering, hereby join the Company's request that the
effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will
be declared effective at 5:00 p.m., Eastern Time, on Tuesday, August 12, 2025, or as soon as practicable thereafter.
Pursuant
to Rule 460 under the Securities Act, we, as the representative of the several underwriters, wish to advise you that there will be distributed
to each Underwriter or dealer, who is reasonably anticipated to participate in the distribution of the securities, as many copies of
the proposed form of preliminary prospectus as appears to be reasonable to secure adequate distribution of the preliminary prospectus.
We,
the undersigned, as representatives of the several underwriters, have complied and will comply, and we have been informed by the participating
underwriters that they have complied and will comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934,
as amended.
Very
truly yours,
DOMINARI
SECURITIES LLC
/s/
Eric Newman
Name:
Eric
Newman
Title:
Executive
Vice President, Head of Investment Banking